Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide

scientific article published on March 1, 1991

Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0042-6822(91)90465-N
P953full work available at URLhttps://api.elsevier.com/content/article/PII:004268229190465N?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:004268229190465N?httpAccept=text/xml
P698PubMed publication ID1704654

P2093author name stringW. S. Robinson
S. Yuasa
Q. Pham
P. L. Marion
R. C. Cheung
P2860cites workDNA sequencing with chain-terminating inhibitorsQ22066207
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymeraseQ26778389
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectorsQ26778475
A simple method for displaying the hydropathic character of a proteinQ26778481
Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.Q35141530
Predicted secondary structure similarity in the absence of primary amino acid sequence homology: hepatitis B virus open reading framesQ36259946
Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S proteinQ36802452
Identification and localization of pre-s-encoded polypeptides from woodchuck and ground squirrel hepatitis virusesQ36855836
Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particlesQ36887249
Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frameQ36902925
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequencesQ36913034
The molecular biology of the hepatitis B virusesQ39511089
Molecular cloning and sequence analysis of duck hepatitis B virus genomes of a new variant isolated from Shanghai ducksQ42643409
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizingQ43715300
Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducksQ43774248
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particlesQ44396308
Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virusQ45836434
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface proteinQ45843535
Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protectiveQ45847063
Mutation rate of the hepadnavirus genomeQ58396490
The hepatitis B virusQ59051957
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatitis BQ6853
Hepatitis B virusQ6844
P304page(s)14-21
P577publication date1991-03-01
P1433published inVirologyQ7934867
P1476titlePeptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide
P478volume181

Reverse relations

cites work (P2860)
Q36631092A cell surface protein that binds avian hepatitis B virus particles.
Q24527304Carboxypeptidase D is an avian hepatitis B virus receptor
Q35868031Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.
Q36650162Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product
Q40015431Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation
Q46007395Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.
Q39642388Enhancement of hepatitis B virus infection by noninfectious subviral particles.
Q48103866Establishment of a yeast-based VLP platform for antigen presentation.
Q40048570Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.
Q33855246Hepatitis B virus biology
Q27318278Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes
Q45413516Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus
Q40677965Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.
Q84867941In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins
Q43647008In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein
Q35851099Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection
Q51473519Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.
Q33642700Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction
Q35876475Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis.
Q24563902Viral and cellular determinants involved in hepadnaviral entry

Search more.